Professional Snapshot
Professional Education
| B.A.: | Harvard University, Biochemical Sciences (1997) |
| Doctor of Medicine: | Stanford University, (2004) |
| Doctor of Philosophy: | Stanford University, (2004) |
| Residency: | Duke University Medical Center, Internal Medicine (2006) |
| Fellowship: | Stanford University, Oncology |
Faculty Advisor
Web Site Links
Scientific Focus
Publications
- Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy. BioDrugs. 2009; (5): 289-304
- Pemetrexed disodium for the treatment of NSCLC: an update. Drugs Today (Barc). 2008; (9): 669-78
- Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am J Pathol. 2007; (5): 1793-805
- Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. Cell Cycle. 2006; (14): 1569-73
- Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev Cell. 2003; (6): 813-26
Help